Answers are grounded in this paper and cite their sources.
This study presents the first phytochemical characterisation and validated HPLC quantification method for the dichloromethane root extract of Rennellia borneensis Baill. (Rubiaceae). LC-MS/MS dereplication and molecular networking were performed in negative ionisation mode, a condition strategically selected to optimise the detection of acidic anthraquinones and phenolic compounds. Integrating SIRIUS and GNPS tools, 17 compounds were annotated, including anthraquinones, flavonoids, isoflavonoids, and a triterpenoid. Two markers: 3-hydroxy-2-methyl-9,10-anthraquinone 1 (4.41 μg/mg) and rubiadin 2 (1.21 μg/mg) were isolated for the first time from this species and quantified using a validated HPLC method. These findings establish R. borneensis as a chemically rich species and provide a scientific foundation for future bioactivity-guided research and the development of standardised herbal products.
No takes yet. Share an insight, caveat, or question.
Rushdan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: